FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3036701712> ?p ?o ?g. }

• W3036701712 endingPage "522" @default.
• W3036701712 startingPage "517" @default.
• W3036701712 abstract "Abstract Multiple myeloma has extremely heterogeneous outcomes. Among prognostic factors, t(4;14) and del(17p) are rare oncogenic events associated with very poor prognosis. In an exploratory case‐control study, we compared the combination of Busulfan‐Melphalan or TBI‐Melphalan with high dose Melphalan as a conditioning regimen in a series of 48 patients with del(17p) or t(4;14). These regimens were preceded by a Bortezomib‐containing induction. Progression‐free survival (PFS) was the primary endpoint whereas overall survival (OS) and complete response (CR) rate were the secondary endpoints. Twenty consecutive cases of high‐risk myeloma received a reinforced conditioning regimen of Busulfan 0.8 mg/kg x4/j IV from day‐6 to day‐3 pre‐ graft (BuMel) or total body irradiation (TBI) 12 Gy (TbiMel), having received Melphalan 140 mg/m 2 at day‐2 pre‐graft. These cases were matched to 28 controls treated with Melphalan 200 mg/m 2 at day‐2 (Mel200). After intensification ± consolidation, with a median follow‐up of 6.3 years, the CR rate was higher in the BuMel/TbiMel group (65% vs 50%, P = .006). No differences were observed between both groups in terms of PFS and OS ( P = .96). PFS in patients with a del(17p) mutation tended to be superior in the BuMel/TbiMel group. Our exploratory study shows that reinforcing the intensification regimen with Busulfan or TBI does not seem to improve the prognosis associated to t(4;14) and del(17p) abnormalities." @default.
• W3036701712 created "2020-06-25" @default.
• W3036701712 creator A5011226625 @default.
• W3036701712 creator A5016941619 @default.
• W3036701712 creator A5040449820 @default.
• W3036701712 creator A5041945426 @default.
• W3036701712 creator A5064211339 @default.
• W3036701712 creator A5066745584 @default.
• W3036701712 date "2020-07-29" @default.
• W3036701712 modified "2023-10-01" @default.
• W3036701712 title "Exploratory analysis of intensified conditioning as first line treatment for patients with high risk multiple myeloma" @default.
• W3036701712 cites W1916555325 @default.
• W3036701712 cites W1975542133 @default.
• W3036701712 cites W1981527160 @default.
• W3036701712 cites W1995310604 @default.
• W3036701712 cites W2001813071 @default.
• W3036701712 cites W2009427822 @default.
• W3036701712 cites W2017303578 @default.
• W3036701712 cites W2028195916 @default.
• W3036701712 cites W2075175917 @default.
• W3036701712 cites W2095124784 @default.
• W3036701712 cites W2126351771 @default.
• W3036701712 cites W2127143739 @default.
• W3036701712 cites W2127575705 @default.
• W3036701712 cites W2166168793 @default.
• W3036701712 cites W2171728602 @default.
• W3036701712 cites W2318069817 @default.
• W3036701712 cites W2345335050 @default.
• W3036701712 cites W2486629951 @default.
• W3036701712 cites W2614283852 @default.
• W3036701712 cites W2728236509 @default.
• W3036701712 cites W2734974033 @default.
• W3036701712 cites W2782898076 @default.
• W3036701712 cites W2800333276 @default.
• W3036701712 cites W2810358255 @default.
• W3036701712 cites W2924657257 @default.
• W3036701712 cites W2940396472 @default.
• W3036701712 cites W2972305086 @default.
• W3036701712 doi "https://doi.org/10.1002/hon.2767" @default.
• W3036701712 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32569436" @default.
• W3036701712 hasPublicationYear "2020" @default.
• W3036701712 type Work @default.
• W3036701712 sameAs 3036701712 @default.
• W3036701712 citedByCount "0" @default.
• W3036701712 crossrefType "journal-article" @default.
• W3036701712 hasAuthorship W3036701712A5011226625 @default.
• W3036701712 hasAuthorship W3036701712A5016941619 @default.
• W3036701712 hasAuthorship W3036701712A5040449820 @default.
• W3036701712 hasAuthorship W3036701712A5041945426 @default.
• W3036701712 hasAuthorship W3036701712A5064211339 @default.
• W3036701712 hasAuthorship W3036701712A5066745584 @default.
• W3036701712 hasConcept C126322002 @default.
• W3036701712 hasConcept C141071460 @default.
• W3036701712 hasConcept C143998085 @default.
• W3036701712 hasConcept C168563851 @default.
• W3036701712 hasConcept C203092338 @default.
• W3036701712 hasConcept C2776364478 @default.
• W3036701712 hasConcept C2776694085 @default.
• W3036701712 hasConcept C2776755627 @default.
• W3036701712 hasConcept C2777408962 @default.
• W3036701712 hasConcept C2778684742 @default.
• W3036701712 hasConcept C2778880498 @default.
• W3036701712 hasConcept C2780611847 @default.
• W3036701712 hasConcept C2781413609 @default.
• W3036701712 hasConcept C2911091166 @default.
• W3036701712 hasConcept C71924100 @default.
• W3036701712 hasConcept C90924648 @default.
• W3036701712 hasConceptScore W3036701712C126322002 @default.
• W3036701712 hasConceptScore W3036701712C141071460 @default.
• W3036701712 hasConceptScore W3036701712C143998085 @default.
• W3036701712 hasConceptScore W3036701712C168563851 @default.
• W3036701712 hasConceptScore W3036701712C203092338 @default.
• W3036701712 hasConceptScore W3036701712C2776364478 @default.
• W3036701712 hasConceptScore W3036701712C2776694085 @default.
• W3036701712 hasConceptScore W3036701712C2776755627 @default.
• W3036701712 hasConceptScore W3036701712C2777408962 @default.
• W3036701712 hasConceptScore W3036701712C2778684742 @default.
• W3036701712 hasConceptScore W3036701712C2778880498 @default.
• W3036701712 hasConceptScore W3036701712C2780611847 @default.
• W3036701712 hasConceptScore W3036701712C2781413609 @default.
• W3036701712 hasConceptScore W3036701712C2911091166 @default.
• W3036701712 hasConceptScore W3036701712C71924100 @default.
• W3036701712 hasConceptScore W3036701712C90924648 @default.
• W3036701712 hasIssue "4" @default.
• W3036701712 hasLocation W30367017121 @default.
• W3036701712 hasLocation W30367017122 @default.
• W3036701712 hasOpenAccess W3036701712 @default.
• W3036701712 hasPrimaryLocation W30367017121 @default.
• W3036701712 hasRelatedWork W1670193918 @default.
• W3036701712 hasRelatedWork W1818531089 @default.
• W3036701712 hasRelatedWork W2022680061 @default.
• W3036701712 hasRelatedWork W2051417565 @default.
• W3036701712 hasRelatedWork W2095124784 @default.
• W3036701712 hasRelatedWork W2371863758 @default.
• W3036701712 hasRelatedWork W2417289880 @default.
• W3036701712 hasRelatedWork W2464864727 @default.
• W3036701712 hasRelatedWork W3032436580 @default.
• W3036701712 hasRelatedWork W3086530429 @default.

• next